PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26459237-7	2016	Our testing results demonstrate that the DOX protocol can efficiently predict accurate geometries for all 15 HMGR-statin crystal complexes without exception.	Doxorubicin	41-44	high mobility group AT-hook 1	Homo sapiens	109-113	
26084422-0	2016	Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.	Doxorubicin	21-31	high mobility group AT-hook 1	Homo sapiens	49-54	
26084422-0	2016	Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.	Doxorubicin	21-31	high mobility group AT-hook 1	Homo sapiens	102-107	
26084422-3	2016	We have chosen 27 bp DNA sequence from a regulatory region of hmga1 promoter and studied its interaction with adriamycin (ADM) and in vitro expression of HMGA1 in the presence of ADM in HeLa cell line.	Doxorubicin	110-120	high mobility group AT-hook 1	Homo sapiens	62-67	
26084422-3	2016	We have chosen 27 bp DNA sequence from a regulatory region of hmga1 promoter and studied its interaction with adriamycin (ADM) and in vitro expression of HMGA1 in the presence of ADM in HeLa cell line.	Doxorubicin	122-125	high mobility group AT-hook 1	Homo sapiens	62-67	
21336378-0	2011	Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.	Doxorubicin	15-25	high mobility group AT-hook 1	Homo sapiens	52-57	
25313540-0	2014	Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.	Doxorubicin	15-26	high mobility group AT-hook 1	Homo sapiens	56-61	
25313540-0	2014	Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.	Doxorubicin	15-26	high mobility group AT-hook 1	Homo sapiens	126-131	
25313540-4	2014	In the present study, we report interaction of doxorubicin (DOX) with a short deoxyoligonucleotide (-1917 to -1940) within a regulatory element of hmga1 and its subsequent effect on expression of HMGA1 in breast cancer MCF7 cells.	Doxorubicin	47-58	high mobility group AT-hook 1	Homo sapiens	147-152	
25313540-4	2014	In the present study, we report interaction of doxorubicin (DOX) with a short deoxyoligonucleotide (-1917 to -1940) within a regulatory element of hmga1 and its subsequent effect on expression of HMGA1 in breast cancer MCF7 cells.	Doxorubicin	47-58	high mobility group AT-hook 1	Homo sapiens	196-201	
25313540-4	2014	In the present study, we report interaction of doxorubicin (DOX) with a short deoxyoligonucleotide (-1917 to -1940) within a regulatory element of hmga1 and its subsequent effect on expression of HMGA1 in breast cancer MCF7 cells.	Doxorubicin	60-63	high mobility group AT-hook 1	Homo sapiens	147-152	
25313540-4	2014	In the present study, we report interaction of doxorubicin (DOX) with a short deoxyoligonucleotide (-1917 to -1940) within a regulatory element of hmga1 and its subsequent effect on expression of HMGA1 in breast cancer MCF7 cells.	Doxorubicin	60-63	high mobility group AT-hook 1	Homo sapiens	196-201	
25313540-6	2014	Reduced expression of HMGA1 by ~ 60% both at mRNA and protein level and associated cell death in presence of DOX was observed in breast cancer cells.	Doxorubicin	109-112	high mobility group AT-hook 1	Homo sapiens	22-27	
21336378-0	2011	Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.	Doxorubicin	15-25	high mobility group AT-hook 1	Homo sapiens	87-92	
21336378-4	2011	The present paper deals with the binding of a widely used chemotherapeutic agent, adriamycin (ADM), to hmg a1 gene promoter (-304 to -284), 21RY, and its effect on the expression of hmga1 at the mRNA and protein levels and further its cytotoxic efficacy in A431 cells.	Doxorubicin	82-92	high mobility group AT-hook 1	Homo sapiens	182-187	
21336378-4	2011	The present paper deals with the binding of a widely used chemotherapeutic agent, adriamycin (ADM), to hmg a1 gene promoter (-304 to -284), 21RY, and its effect on the expression of hmga1 at the mRNA and protein levels and further its cytotoxic efficacy in A431 cells.	Doxorubicin	94-97	high mobility group AT-hook 1	Homo sapiens	182-187	
16540646-6	2006	Moreover, inhibition of HMGA1 expression in thyroid cancer cells resulted in increased p53 oligomerization in response to the DNA-damaging agent doxorubicin.	Doxorubicin	145-156	high mobility group AT-hook 1	Homo sapiens	24-29